Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep:83:102958.
doi: 10.1016/j.drugpo.2020.102958.

COVID-19 and the health of people who use drugs: What is and what could be?

Jason Grebely  1 , Magdalena Cerdá  2 , Tim Rhodes  3
Affiliations

COVID-19 and the health of people who use drugs: What is and what could be?

Jason Grebely et al. Int J Drug Policy. 2020 Sep.

Abstract

SARS-CoV-2, the virus that causes COVID-19, has changed the world as we know it, and continues to do so. How COVID-19 affects people who use drugs, the environments in which they live, and capacities of response, warrants immediate attention. This special issue begins to map how COVID-19 is altering the health of people who use drugs, including in relation to patterns of drug use, service responses, harms that may relate to drug use, interventions to reduce risk of harms, COVID-19 health, and drug policies. We emphasise the need to envisage COVID-19 and its effects as a matter of intersecting 'complex adaptive systems': that is, the impacts of COVID-19 extend beyond the virus and related illness conditions to encompass multiple social, cultural, economic, policy and political effects; and these affect the health of people who use drugs directly as well as indirectly by altering the risk and enabling environments in which they live. We synthesize emergent evidence on the impact of COVID-19 on the health of people who use drugs. A key concern we identify is how to sustain policy and service delivery improvements prompted by COVID-19. We need to maintain an ethos of emergent adaptation and experimentation towards the creation of safer environments in relation to the health of people who use drugs.

Keywords: Drug users; Harm reduction; Injecting; PWID; SARS-CoV-2; Treatment.

PubMed Disclaimer

References

    1. Akiyama M.J., Spaulding A.C., Rich J.D. Flattening the curve for incarcerated populations - Covid-19 in jails and prisons. The New England Journal of Medicine. 2020;382:2075–2077. - PMC - PubMed
    1. AMA. (2020). Issue brief: Reports of increases in opioid-related overdose and other concerns during COVID pandemic. American Medical Association
    1. Arcadepani F.B., Tardelli V.S., Fidalgo T.M. The SARS-Cov-2 threat in Cracolandia, an open-air drug use scene in Brazil. International Journal of Drug Policy. 2020;83:102835. - PMC - PubMed
    1. Bagcchi S. Stigma during the COVID-19 pandemic. The Lancet Infectious Diseases. 2020;20:782. - PMC - PubMed
    1. Baggett T.P., Racine M.W., Lewis E., De Las Nueces D., O'Connell J.J., Bock B. Addressing COVID-19 among people experiencing homelessness: description, adaptation, and early findings of a multiagency response in Boston. Public Health Reports. 2020;135:435–441. - PMC - PubMed

Publication types